Shandong Xinhua Pharmaceutical Renews Trademark Licence

Shandong Xinhua Pharmaceutical Company Limited Class H (HK:0719) has released an update.

Shandong Xinhua Pharmaceutical Company Limited has renewed its trademark licence agreement with Shandong Xinhua Pharmaceutical Branch of Hualu Holdings Co. Ltd., extending the exclusive right to use the ‘Xinhua’ trademark until the end of 2025. This renewal is part of an ongoing connected transaction, reflecting the company’s strategic commitment to maintaining its brand presence. The agreement has implications under the Hong Kong Stock Exchange’s Listing Rules, ensuring compliance with reporting and review requirements.

For further insights into HK:0719 stock, check out TipRanks’ Stock Analysis page.